首页 | 官方网站   微博 | 高级检索  
     

康莱特联合化疗对NSCLC患者生活质量改善的临床研究
引用本文:吕喜英,张秀琴,李青山. 康莱特联合化疗对NSCLC患者生活质量改善的临床研究[J]. 临床肺科杂志, 2004, 9(4): 342-343
作者姓名:吕喜英  张秀琴  李青山
作者单位:067000,河北承德医学院附属医院肿瘤内科;067000,河北承德医学院附属医院肿瘤内科;067000,河北承德医学院附属医院肿瘤内科
摘    要:目的 探讨康莱特注射液对联合化疗与单纯化疗改善晚期非小细胞肺癌 (NSCL C)患者的生活质量临床意义。方法 采取随机对照分组 ,治疗组 30例为康莱特联合化疗 ;对照组 30例为单纯化疗。结果 治疗组有效率为 36 .7% ,对照组为 2 3.3% ,有显著性差异 (P<0 .0 5 ) ,在控制疼痛、体重及 karnofsky评分等方面治疗组均优于对照组 ,差异有显著性。结论 康莱特注射液联合化疗可提高化疗疗效、改善患者生活质量

关 键 词:康莱特  生活质量  化疗  非小细胞肺癌
修稿时间:2004-03-06

Clinical study on quality of life for chemotherapy combined with langlaite in non-small cell lung cancer
Xiying Lv Xiuqin Zhang Qingshan Li Affiliated Hospital of Chengde Medical College,Chengde ,China. Clinical study on quality of life for chemotherapy combined with langlaite in non-small cell lung cancer[J]. Journal of Clinical Pulmonary Medicine, 2004, 9(4): 342-343
Authors:Xiying Lv Xiuqin Zhang Qingshan Li Affiliated Hospital of Chengde Medical College  Chengde   China
Affiliation:Xiying Lv Xiuqin Zhang Qingshan Li Affiliated Hospital of Chengde Medical College,Chengde 067000,China
Abstract:Objective To evaluate the clinical significance of chemotherapy with and without kanglaite in the non-small cell lung cancer (NSCLC) patients to improve their quality of life.Methods The treatment group received Kanglaite and chemotherapy, and the control group received simple chemotherapy . The two groups were enrolled by a randomly contrast method. Results The effective rate in the treatment group was 36.7% ,in the control group it was 23.3: p<0.05. There was a greater improvement for the treatment group on pain, weight and karnofsky.Conclusion Kanglaite combined with chemotherapy can enhance the therapeutic effect, and improve the quality of life in NSCLC patients.
Keywords:Kanglaite Quality of life Chemotherapy NSCLC
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号